Where does Vitrivax's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vitrivax's 1 recorded funding rounds.

Premier Alternatives

Vitrivax

Discovery Tools (Healthcare) · Boulder, CO · Founded 2014 · Privately Held (backing)

Developer of thermostable vaccine formulations designed to eliminate barriers to global vaccination. Vitrivax is based in Boulder, CO and was founded in 2014. It was valued at $69.4 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $38.2 million across 1 recorded round; the latest was a $29.4 million Series B in Nov 2025.

PMV mark · valuation

$69.4M

Oct 2026

Priced at

its later-stage round

Nov 2025

Total raised

$38.2M

Last round

Later Stage VC (Series B)

Nov 2025

Cap table — not yet on record

Vitrivax's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Vitrivax with a free account

·The complete investor list: 15 names
·Watch Vitrivax: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Vitrivax

Where does Vitrivax's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vitrivax's 1 recorded funding rounds.